LIU Zengping

LIU Zengping

LIU Zengping

Principal Investigator

zengpingliu@nus.edu.sg

Educational Qualifications

2009.07 Bachelor of Medicine, Master of Medicine, School of Medicine, Wuhan University, P.R. China
2013.11 Doctor of Medicine, University Eye Hospital Bonn, University of Bonn, Germany

 

Work Experience

2025.07-present Assistant Professor (Tenure Track), Department of Ophthalmology, National University of Singapore, Singapore
2026.01-present Assistant Professor (Tenure Track), Department of Biomedical Engineering, National University of Singapore, Singapore
2025.08-present Senior Scientist II (joint appointment), Institute of Molecular and Cell Biology, A*Star, Singapore
2026.03-present Research Scientist (joint appointment), Singapore Eye Research Institute (SERI), Singapore

 

Research Interests

Stem cell biology, tissue engineering (scaffold development), surgical animal models, and clinical research.

 

Honors & Awards

2026. 02 Clinician Scientist Award, National Medical Research Council (NMRC), Singapore
2025. 12 Research Accreditation Programme- Award for Financial Year 2023 Scientific Publications, Singapore Eye Research Institute, Singapore
2023. 10 Yong Investigator Award, Tissue Engineering and Regenerative Medicine International Society (TERMIS), Hong Kong, China

 

Representative Publications

48 publications, total IF 316.964, H-index 21, FWCI 2.31, 28 articles in Top 10%, 41 articles in Q1.

[1]  Liu H, Wong DSL, Parikh BH, Hao M, Tan QSW, Chee PL, Lou X, Kai D, Lingam G, Huang D*, Su X*, Liu Z*, Single-cell-pore-sized 3D printed scaffolds for retinal pigment epithelial cell therapy. Acta Biomater., 2025; DOI: 10.1016/j.actbio.2025.10.033.

[2]  §Liu Z*, Wong DSL, Parikh BH, Li J, Al-Mubaarak A, Liu H, Yang B, Bhargava M, Li Z, Loh XJ*, Su X*, Development of a biodegradable smooth-surface microcarrier for retinal pigment epithelial cell expansion and maturation. Biomaterials, 2025; DOI: 10.1016/j.biomaterials.2025.123742

[3]  Ali SM, Parikh BH, Tan QSW, Hübner B, Kozyrina AN, Banerjee A, Zhao J, Goh D, Bogireddi H, Yeo SW, Wong DSL, Xu J, Tan KC, Liu Z, Le Y-Z, Barathi VA, Cheong KH, Di Russo J, Ludwig A, Hunziker W*, Su X*, ZO-1/Tjp1 and ZO-2/Tjp2 deletion in retinal pigment epithelium causes progressive retinal degeneration, iScience 2025; DOI: 10.1016/j.isci.2025.113673.

[4]  Zhao X, Lin Q, Seah I, Tan QSW, Goh RZR, Mehta KN, Liu Z, Tan A, How SEA, Sim B, Mota-Santiago P, Kirby N, Leow Y, Lim CC, Boo YJ, Goh SS, Lim JYC, Loh XJ, Su X. One-year ultralong intravitreal release of tyrosine kinase inhibitor from supramolecular temperature-responsive hydrogel. Biomacromolecules, 2025; DOI: 10.1021/acs.biomac.5c01212.

[5]  Chee PL, Hao M, Liu G, Yew PYM, Kim E, Liu H, Sathasivam T, Xu G, Liu Z*, Kai D*. Functional scaffolds design strategies for retinal repair and regeneration. Mater. Today Bio., 2025; DOI: 10.1016/j.mtbio.2025.102283.

[6]  §Schulz A*, Keskar M, Swindle-Reilly KE, Junge V, Parikh BH, Su X, Liu Z*, Seah I. Replacing the vitreous body with hydrogels: rationale and strategies. Prog. Retin. Eye Res. 2025; DOI: 10.1016/j.preteyeres.2025.101389.

[7]  §Wang W, Wang N, Zhao X, Su X*, Liu Z*. Recent advancements in polymer science for retinal diseases: New frontiers in drug delivery systems. APL Bioeng. 2025; DOI: 10.1063/5.0264382. Featured Article.

[8]  Soundararajan L, Surendran H, Patlolla N, Battu R, Stoddard J, Arrizabalaga S, Liu Z, Lingam G, Su X, Ryals RC, Pal R. Allogeneic RPE cell suspension manufactured at scale demonstrating preclinical safety and efficacy led to IND approval. npj Reg. Med., 2025; 10:19. DOI: 10.1038/s41536-025-00407-0.

[9]  Xu Y, Liu X, Wu N, Long Y, Ren J, Wang Y, Su X, Liu Z, Fujinami-Yokokawa Yu, Fujinami K, Chen F, Meng X, Liu Y. Investigating microperimetric features in bietti crystalline dystrophy patients: a cross-sectional longitudinal study in a large cohort. Invest. Ophthalmol. Vis. Sci. 2024; 65(13):27. DOI: 10.1167/iovs.65.13.27.

[10] §Liu H, Huang SS, Lingam G, Kai D, Su X*, Liu Z*. Advances in retinal pigment epithelial cell transplantation for retinal degenerative diseases. Stem Cell Res. Ther, 2024; 15:390. DOI: 10.1186/s13287-024-04007-5.

 

NUS Webpage

https://cde.nus.edu.sg/bme/staff/dr-liu-zengping/


Other Investigators

CHEN Nanguang
CHEN Nanguang

Adjunct Chief Principal Investigator

biecng@nus.edu.sg
CHEN Xudong
CHEN Xudong

Chief Principal Investigator

elechenx@nus.edu.sg
GUO Yongxin
GUO Yongxin

Adjunct Chief Principal Investigator

yongxin.guo@nus.edu.sg
HUANG Dejian
HUANG Dejian

Chief Principal Investigator

fsthdj@nus.edu.sg
HUANG Zhiwei
HUANG Zhiwei

Senior Principal Investigator

biehzw@nus.edu.sg
LEE Chengkuo
LEE Chengkuo

Senior Principal Investigator

elelc@nus.edu.sg
LI Dan
LI Dan

Senior Principal Investigator

dan.li@nus.edu.sg
LI Jun
LI Jun

Chief Principal Investigator

bielj@nus.edu.sg
LIM CHWEE TECK
LIM CHWEE TECK

Chief Principal Investigator

ctlim@nus.edu.sg
LIU Shaoquan
LIU Shaoquan

Senior Principal Investigator

fstlsq@nus.edu.sg
LIU Xiaogang
LIU Xiaogang

Chief Principal Investigator

chmlx@nus.edu.sg
ONG Soh Khim
ONG Soh Khim

Senior Principal Investigator

mpeongsk@nus.edu.sg
PANG Bo
PANG Bo

Principal Investigator

bopang@nus.edu.sg
QIU Anqi
QIU Anqi

Adjunct Senior Principal Investigator

bieqa@nus.edu.sg
YE Zhisheng
YE Zhisheng

Senior Principal Investigator

yez@nus.edu.sg
YU Haoyong
YU Haoyong

Senior Principal Investigator

bieyhy@nus.edu.sg
ZHANG Dachuan
ZHANG Dachuan

Principal Investigator

dachuan.zhang@nus.edu.sg
ZHOU Jiangtao
ZHOU Jiangtao

Principal Investigator

jtzhou@nus.edu.sg
ZHOU Weibiao
ZHOU Weibiao

Chief Principal Investigator

weibiao@nus.edu.sg
ZHOU Zhiying
ZHOU Zhiying

Senior Principal Investigator

elezzy@nus.edu.sg
ZHU Chunxiang
ZHU Chunxiang

Senior Principal Investigator

elezhucx@nus.edu.sg